Related News:
- FDA approves Roche’s Lunsumio, a first-in-class…
- European Commission approves Roche’s first-in-class…
- FDA grants priority review to Roche’s bispecific…
- CHMP recommends EU conditional approval of Roche’s…
- US FDA grants Priority Review to Roche’s Tecentriq…
- New data for Roche’s Columvi and Lunsumio presented…